REG - Hikma Pharmaceutical - Block listing Interim Review
RNS Number : 2475EHikma Pharmaceuticals Plc16 October 2018
Block Listing Six Monthly Return
Information provided on this form must be typed or printed electronically and provided to an RIS.
LEI: 549300BNS685UXH4JI75
Date: 16 October 2018
Name of applicant:
Hikma Pharmaceuticals PLC
Name of scheme:
Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP")
&
Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP")
&
Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("MIP")
&
Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP")
Period of return
From:
1 April 2018
To:
30 September 2018
Balance of unallotted securities under scheme(s) from previous return:
SOP: 792,700 ordinary shares of 10 pence
LTIP: 107,061 ordinary shares of 10 pence
MIP: 978,116 ordinary shares of 10 pence
EIP: 1,092,242 ordinary shares of 10 pence
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
SOP: 0 ordinary shares of 10 pence
LTIP: 0 ordinary shares of 10 pence
MIP: 0 ordinary shares of 10 pence
EIP: 0 ordinary shares of 10 pence
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
SOP: 0 ordinary shares of 10 pence
LTIP: 4,347 ordinary shares of 10 pence
MIP: 192,956 ordinary shares of 10 pence
EIP: 377,718 ordinary shares of 10 pence
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
SOP: 792,700 ordinary shares of 10 pence
LTIP: 102,714 ordinary shares of 10 pence
MIP: 785,160 ordinary shares of 10 pence
EIP: 714,524 ordinary shares of 10 pence
Name of contact:
Peter Speirs
Telephone number of contact:
0207 399 2772
Block Listing Six Monthly Return
Stock Option Plan ("SOP")
Date
Block Listing
Shares Issued
Balance (Headroom)
Notes
01/04/2018
-
-
792,700
Blocklisting return on 01/04/18
Block Listing Six Monthly Return
Long Term Incentive Plan ("LTIP")
Date
Block Listing
Shares Issued
Balance (Headroom)
Notes
01/04/2018
-
-
107,061
Blocklisting return on 01/04/18
31/08/2018
4,347
102,714
Block Listing Six Monthly Return
Management Incentive Plan ("MIP")
Date
Block
Listing
Shares
Issued
Balance
(Headroom)
Notes
01/04/2018
0
0
978,116
Blocklisting return on 01/04/18
19/04/2018
0
1,096
977,020
11/05/2018
0
2,118
974,902
11/05/2018
0
4,407
970,495
14/05/2018
0
1,485
969,010
16/05/2018
0
172,195
796,815
18/05/2018
0
910
795,905
21/05/2018
0
551
795,354
29/05/2018
0
1,660
793,694
29/05/2018
0
759
792,935
06/06/2018
0
764
792,171
06/06/2018
0
1,341
790,830
06/06/2018
0
1,323
789,507
28/08/2018
0
2,027
787,480
06/09/2018
0
1,903
785,577
20/09/2018
0
417
785,160
Block Listing Six Monthly Return
Executive Incentive Plan ("EIP")
Date
Block Listing
Shares Issued
Balance (Headroom)
Notes
01/04/2018
0
0
1,092,242
Blocklisting return on 01/04/18
02/04/2018
0
58,010
1,034,232
12/04/2018
0
7,367
1,026,865
16/05/2018
0
46,224
980,641
16/05/2018
0
69,297
911,344
16/05/2018
0
40,000
871,344
23/05/2018
0
5,493
865,851
23/05/2018
0
132,439
733,412
31/08/2018
0
5,374
728,038
12/09/2018
0
6,514
714,524
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDBLRGGGBPUUPRGAQ
Recent news on Hikma Pharmaceuticals
See all newsREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
Announcement